SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Cannabis >

Advantis Corp. (ADVT)

ADVT RSS Feed
Add ADVT Price Alert      Hide Sticky   Hide Intro
Moderator: buckyeye1978, Papa Bear, DaBenDan, Teslonian, $Pistol Pete$
Search This Board: 
Last Post: 5/25/2017 11:06:19 PM - Followers: 267 - Board type: Free - Posts Today: 0

  ADVANTIS CORPORATION
                                                                                                                           
               cannibis_loader  
 
   
                                                                                             
            http://www.advantiscorp.com/

               
Advantis Corporation (ADVT) is focused on helping people take control of their health and pain management needs. By creating strategic partnerships with innovative companies in the nutraceutical and alternative health care industries, Advantis is uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Acquiring ownership in developing companies allows Advantis to provide consultation to improve product lines, expand distribution channels, and heighten brand value. With the healthcare and pain management sectors forecasting staggering growth, Advantis identifies and partners with those companies that possess the potential to capitalize on this trend.
                                                                                                                               
Acquisitions and product developments ensure that Advantis reaches sustainable revenue growth in the near-term as it prepares for future market opportunities. CEOChristopher Swartz envisions the success of Advantis Corporation through strengthened partnerships, innovative product development, and sustained focus on revenue-producing strategies. With the help of a diverse and skilled management team, Swartz has navigated Advantis towards enhancing its footprint in the evolving legal cannabis business, holistic pain management, and healthcare industries. Expertise in the legal aspects of the medical cannabis industry allows Advantis to work within the framework of the law to target opportunities along the supply-chain of this untapped, explosive growth industry.



 

Where We are as a Company:
 

1.Our goal has always been to create a great CBD product line. We have partnered withwww.Hemp2health.com out of Colorado as a source for the CBD oil. We have done our research and like their focus on chemical free growing and extracting. Lab tests show consistent quality and concentration and provide proof that it is free of chemicals. They have a patented cannabis strain that is very high in CBD.
 

2.We have also Licensed a Technology for preservation of Cannabis flowers. N2pack.com

 

3.We are also starting a finance division. Personal loans for Manufactures and retailers in the Cannabis space. We are partnering with a lead generation company https://leafhead.com/ . They have a very large following on their network of qualified professionals in this space.

 

 


ADVANTIS CORPORATION  PRODUCTS AND HOLDINGS:
Advantis Corp.    


 

sequence-therapy-fitness  Oregon Advantis Cannabis LLC  Washington Advantis Cannabis LLC
Amster-Can Premium Cannibis organically grown naturally preserved  natural-elements-web-photoNug Smasher Rosin Press

 

SEQUENCE THERAPY + FITNESS
Advantis Corp. recently acquired a 25% stake in Sequence Therapy, LLC. The company has an established client base of physicians and pain management specialists it works with to research and develop innovative techniques to treat the source of pain, rather than the symptoms. A laboratory gymnasium is maintained to study, educate, license and develop pain management techniques for patients and physicians to utilize. Sequence Therapy has developed an application over the past 10 years that it provides to health care professionals (under licensing agreement) that prescribe sequence therapy exercises for chronic pain.

Treatment of chronic pain is a $560 billion industry because physicians often use highly addictive opiates to treat the symptoms of pain, which usually exacerbates the problem. Sequence Therapy believes there is a better way. The company is developing non-addictive CBD (a cannabis extract) formulae that can be paired with sequenced therapy programs that can aid the execution of exercises targeting the source of chronic pain. Using the natural pain suppressant along with prescribed exercises will allow patients to safely reduce and in some cases rid themselves of chronic pain, without the damaging side effects of opiates.The company currently earns $500,000 in annual revenue from its existing client base; Advantis is executing a strategy to exponentially increase revenue through targeted marketing, branding, and distribution channels.

Oregon Advantis Cannabis, Washington Advantis Cannabis
Advantis Corp strives to be at the forefront of the coming “Green Rush”. Formed in 2015, Oregon Advantis Cannabis LLC and Washington Advantis Cannabis LLC are in the final stages of solidifying relationships with current producers and distributors of cannabis with the intent to acquire a majority share and controlling interest.

 

Product Info:

 

Natural Elements
Natural Elements, Inc. is a non-profit, mutual benefit corporation that operates in accordance with California Health & Safety Sec. 11362(B)(1)(A) & 11362.7(H) Prop 215 S.B. 420. We are dedicated to providing a high quality and efficient, medical marijuana delivery service to all of our patients. Specializing in locally grown organic medicines, and edible products, we serve all qualified patients.



Image result for advantis corporationImage result for latest news

 

Advantis Corp. To Produce Amstercan Branded Vape Pens

 

NEWPORT BEACH, CA--(Marketwired - Feb 13, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is launching its own line of premium quality Amstercan vape pens. Laboratory testing confirms that the new formulation of Amstercan vape oils contain the highest concentration of THC, when compared with the top performing brands in the market space.

Advantis began jointly developing these oil strains with medical marijuana cooperative, Natural Elements, back in July of 2016. "We are thrilled to be able to offer packaging solutions for Natural Elements' highest quality cannabis strains and oils; as well as our partners at Hemperor's Club, and all of the cultivators and cooperatives we work with," Swartz explained. "We helped develop these concentrates and we are finally packaging and cobranding these four strains of Amstercan vape oils. Amstercan's most potent oil has a THC concentration over 85% -- stronger than almost anything out there. We've been helping develop these oils as soon as I began at Advantis." Swartz further commented on how adding another proprietary product alongside a more well-known one will allow for a variety of options for Advantis clients. "I take great pride in what we are doing here," said Swartz. "We've discovered a great synergy with the partners we work with and the products we procure and provide to our growing client base. Advantis is able to pioneer and follow at the same time; delivering innovative new solutions while working with the highest quality partners to ensure Advantis is always associated with only the best of product options."

Swartz talked about the journey that led to the development of the new strains of Amstercan oils. "I've been in the pain management space for a long time," Swartz said. "I've always worked to find innovative solutions; cannabis, its compounds, and delivery methods are the cutting edge of health and pain management science. We work to make sure these oils are 100% organic from seed to cartridge." Swartz elaborated on how he translates his vision into the products he delivers. "We use the best quality cartridges and materials that don't leak or have electronic failures. We have a QR code on our containers so consumers can see the lab test results. We've created an easy process to switch strains without sacrificing quality or unique flavor. Quality, consistency, and innovation. This is how we build our brands to be a trusted name in the marketplace." Swartz commented that Amstercan vape oils should take off as quickly as the cans, themselves. "Like I said, synergy. The same clients that are using our Amstercans and/or rosin presses are now able to purchase the vape pens alongside their current orders."

Marketing has been a key focus with each product Swartz has rolled out, and he says his efforts get easier as the brand gains traction. "We are starting a new internet, marketing and media strategy for this launch," Swartz elaborated. "We have been in communication with a national television producer that is interested in showcasing our company, products, and business model. We are soon to announce a celebrity endorsement. Our manufacturing processes, machinery, and inventory are now at a level where I feel comfortable inviting them in for an interview. I wouldn't exactly say opportunities like this make things easier, but earned media does help get exposure." Swartz ended by saying that there was more to come and that synergy is always at the top of his mind.

Links to Advantis websites can be found at advantiscorp.com, rosin6.com, and amstercan.com

Forward-Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

For further information, contact:
Media Relations Contact
Name: Woo Kim
Director
Organization: Advantis Corporation
Phone: 949-354-3585
Address: 1048 Irvine Ave. #900
Newport Beach, CA 92660
E-mail: info@advantiscorp.com



 

Advantis Corp. Packages Hemperor's Club Premium Cannabis

 

NEWPORT BEACH, CA--(Marketwired - Jan 30, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) agreed to use Amstercan to package the most premium line of cannabis for one of Southern California's leading exotic flower and vape pen producers, Hemperor's Club.

Advantis has already begun full-scale production for Hemperor's Club, who is a member/provider for several Southern California dispensaries. "This is an excellent opportunity to spread the name and idea of Amstercan to become a more recognized brand name in the industry," Advantis CEO, Christopher Swartz, said. "Hemperor's Club has done a great job of doing this themselves, so this is a mutually beneficial relationship. Hemperor's club will elevate the image of their most premium brands, and that will lead to another consistent revenue stream for Amstercans." Hemperor's Club services thousands of Southern California member/patients with the supply of their most exotic strains of cannabis and vape pens.

"We continue to make progress with consistent revenue streams to support our consistent growth," Swartz said. "Teaming up with Hemperor's Club... a well-known name in the industry... they will be having a well-known personality representing their products to get even more exposure; this will further expand our reach in the marketplace." Swartz has alluded to a well-known personality in previous statements, but declined to expand on the identity of the said personality. "Very soon," Swartz replied when asked about when he would reveal the identity. "Very soon." Swartz concluded by saying that he was proud of the consistent revenue streams the company is establishing, and he will continue to find ways to synergize. "With new clients comes several new opportunities in many cases. It's great. We are being very careful not to expand too fast, and at the same time we are finding ways to establish the revenue streams necessary to sustain responsible growth." Advantis currently has established revenue streams for Amstercan, rosin press products, and additionally markets Hemperor's Club vape pens and tinctures.



Advantis Corp. Developing Rosin Press for Home Use

 

NEWPORT BEACH, CA--(Marketwired - Jan 23, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is currently developing a rosin press designed for home use. The company is adding to its current line up of rosin presses, and is in negotiations to have a well known personality in the cannabis industry represent the Advantis products.

"Advantis is generating revenue and adding to our product lineup at a fever pitch," Advantis CEO, Christopher Swartz stated. "With the continuing success with the sales of the Rosin 6, Nugsmasher, and Nugsmasher Junior rosin presses, we have uncovered demand for a completely untapped market: a smaller, lighter press that independent growers, patients, and users can utilize to create their own rosin." Swartz says the company had previously researched the possibility of manufacturing a home-use press, however the market for it seemed thin. "With rising medical marijuana usage and the new law in California for recreational use... there are thousands of people that grow their own medicine now, and there will be thousands more when the recreational use law takes effect." Swartz cited information Advantis has accumulated as they have been selling their current lineup of products. "The data is clear. Our buyers and partners relate that they consistently receive requests for a press that is more manageable in size and convenience of use." There are currently small presses available in the marketplace, but Swartz says Advantis is developing one that will be more efficient and safer to use.

Advantis sales have grown rapidly as a result of their aggressive marketing efforts. The company has established several partnerships, establishes new clients daily, and is reaching wholesalers through targeted marketing efforts. "Our sales staff is phenomenal, and we are working on augmenting their efforts by working with a well known personality," Swartz said. "We have been approached by several celebrities as we were already looking for a spokesperson. We are now in negotiations." Swartz concluded by saying the announcement would be made shortly once details of negotiations are finalized. "With sales continuing to climb, new additions to our product mix, and earned press we will get with our celebrity partnerships and/or endorsements, Advantis is about to reach the next level."

 

Advantis Corp. Boosts Bottom Line, Reduces Debt

 

NEWPORT BEACH, CA--(Marketwired - Jan 17, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has settled into its new commercial space to meet surging demand of Amstercan, rosin presses, and other products. The company has also announced that it has reduced debt by $250,000.

Advantis CEO, Christopher Swartz, explained how much more productive the company is now that it is taking full advantage of the increased space. "We previously only had access to the Amstercan canning machine during certain hours of the week," Swartz said, "as business began to surge, we quickly moved to find this commercial space. We now have around the clock access, which we need to keep up with the escalating demand." Advantis began marketing Amstercan packaging for premium medical marijuana a little more than three months ago. The company has secured several new clients, including the largest medical marijuana delivery cooperative, Speedweed. Sales began with the first few hundred cans that dispensaries initially used to test market; Advantis clients and partners have since placed orders for over 10,000 Amstercans. "Initial demand has surpassed even our most aggressive projections," Swartz reflected, "and we are securing new clients every week. If we continue this trajectory, we will be household name in the industry very soon." Swartz commented that the new commercial space is what allows the rapid expansion, while a sales force of independent contractors actively engage with the largest California medical marijuana cooperatives and their member-growers. "California is only the beginning," Swartz stated.

Swartz alluded to how the increase in sales is boosting top and bottom line numbers. "I'm excited to deliver fourth quarter numbers, and will be more elated when we report the first quarter numbers," Swartz said. "Providing shareholder value is important to me, and reducing debt is just as paramount as increasing sales. I am proud to announce that we have retired $250,000 of debt." Advantis has recently retired a debt that was contingent upon performance and tenure of a previous company officer. The company is now able to eliminate this debt from the balance sheet, without having to issue new shares or expend company assets. Based on numbers reported on the third quarter balance sheet, total debt has been reduced by almost twenty-five percent. "2017 is the first year we should have more revenue than debt," Swartz concluded, "I could not be more proud of the work that we are doing, and the best is yet to come."

 

Advantis Corp. Rolls Out New Products

NEWPORT BEACH, CA--(Marketwired - Jan 10, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is introducing three new CBD and THC extracts that it will be marketing alongside its current lineup of products.

The move to add Elixicure CBD tincture, Deltacure CBD and THC oils, and Hemperor's Club Vape Pens is a carefully planned sales strategy, according to Advantis CEO, Christopher Swartz. "We've been market testing several products, and these 3 all natural health solutions stood out as the highest in demand. With Amstercans and rosin press technologies taking huge leaps in sales, we are establishing a solid client base in an industry that is continuously thirsty for the most effective, innovative products." Swartz commented on the potential size of the market. "With the amount of Amstercans that are selling, we see a tremendous demand for these targeted, health specific medicines. As an advocate and developer of innovative pain management solutions, Elixicure and Deltacure are the future, and the future is now." CBD tincture is used to provide relief from various sources of pain without the psychoactive effects of THC.

In an effort to keep up with demand and expansion of its current offerings, Advantis is working with an effective marketing and social media expert. "Our marketing efforts are proving to be effective, thanks to the strategy and artistry of our web designer, slash artist, slash marketing expert," Swartz said. "It's true that we have had to ask the manufacturers of our rosin presses to ramp up production, and we are proud of what we've done so far; but we just got to the next level, and it's time to get to the next." Swartz alluded to a potential product endorsement, saying, "We can get a nice boost of publicity as we work to leverage our social media skills to connect with a known social media presence and be seen by hundreds and thousands of followers." Swartz fell short of committing to a specific person or entity, but he says they are currently in talks with some "personalities."

 
 

Advantis Corp. Reviews Progress, Forecasts Revenue Explosion for 2017


  NEWPORT BEACH, CA — (Marketwired) — 12/19/16 — ADVANTIS CORPORATION (OTC PINK: ADVT), concluded its year-end meeting, and announced that 2017 revenue will be the largest in company history.

Advantis CEO, Christopher Swartz, recapped company developments over the course of the year. “The former leadership team did a fantastic job of setting the table for success. There were some challenges that emerged with some of the products, distribution channels, and strategies that Advantis pursued early in the year; decisions were made that established the relationships and laid the groundwork to make Advantis’ recent sales progress possible.” Swartz reflected on some of the low revenue products and efforts to expand in other legal cannabis states. “The leadership team had the right idea, but we just didn’t have the revenue in place to support that kind of growth. We still have active plans to establish ourselves in these other states — we have the necessary organizations, but we first need to ensure a consistent revenue stream to support the expansion. We now see that revenue stream in sight… in fact, revenue is about to explode.”

Swartz was excited to share what company efforts are leading to and how Advantis will evolve in 2017. “Advantis has achieved an important milestone by generating significant sales revenue this quarter,” Swartz exclaimed. “I see this momentum continuing for the foreseeable future, and we are poised to achieve our highest revenue ever in 2017.” This quarter, Advantis has been gaining several new clients for the premium Amstercan and Black Label Amstercan products, and have developed products and partnerships to sell rosin presses, which are very high margin products. The company is additionally establishing partnerships to co-brand strains of cannabis for premium label Amstercan products. “We work with serious cultivators to package their most premium marijuana. Speedweed sells out of their Amstercan orders every week, and each successive reorder is more substantial; between Speedweed and additional clients we secure every week, we are on track to sell almost 15,000 Amstercans by the end of January.” Speedweed is California’s largest medical marijuana delivery service.

Swartz related that the largest source of revenue is being generated by the Rosin6 and Nugsmasher line of rosin presses. “Revenue from our rosin presses will surpass six figures this quarter, and our momentum is gaining steam. We sold three dozen Nugsmasher Jr.’s in the first week, established seven new retail accounts, and will finalize an agreement with the largest online distributor of rosin presses this week.” Swartz stated that 2017 revenues are expected to significantly increase as the company continues to establish new relationships and distribution channels. “Our initial marketing and advertising blitz was a huge success, and Advantis is quickly becoming a trusted name in the industry. I am fully confident that our revenue for 2017 will be in the millions, if these current trends continue.”

Swartz expanded on what these revenue streams mean to the company’s future. “This initial product launch went far better than expected,” Swartz said. “As our brand names gain traction, it will enable us to expand into other areas of the industry. We are in the midst of the great ‘green rush,’ and with this consistent revenue stream, we are positioned to take full advantage of it.” Swartz stopped short of hinting at what is to come, however he commented that he is planning on producing quarterly live interactive video shareholder conferences as business progresses. Swartz will shortly announce registration information so shareholders or potential investors can enroll to be part of the first call. “I do my best to ensure our shareholders are aware of developments as they happen, and I am committed to strengthening shareholder value.” Swartz said there are exciting developments that will be announced in the coming weeks that will further enhance the company’s bottom line. “With growing revenues, burgeoning partnerships, and an established business base, 2017 is the year Advantis arrives,” Swartz concluded


More Advantis Corporation News Can Be Found At:       http://advantiscorp.com/latest-news/  and  https://www.otcmarkets.com/stock/ADVT/news

 

 
 
Share Structure Information 


Transfer Agent:

http://www.pacificstocktransfer.com/wp-content/uploads/logoO1.png
Pacific Stock Transfer
4045 South Spencer Street Suite 403 Las Vegas, NV 89119
Tel: (702) 361-3033 / (800) 785-PSTC Fax: (702) 433-1979

ADVT Security Details    
Share Structure    
Market Value1 $6,800,376 a/o Jan 1, 2017
Authorized Shares 1,000,000,000 a/o Jan 1, 2016
Outstanding Shares 918,969,715 a/o Aug 23, 2016
 

Float: 189,431,544   a/o Jan 1, 2016 

 
http://www.otcmarkets.com/stock/ADVT/quote




ADVT
 
 
 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ADVT
Current Price
Volume:
Bid Ask Day's Range
ADVT News: Advantis Corp. Posts Record First Quarter Revenue 05/22/2017 09:43:05 AM
ADVT News: Advantis Corp. To Begin Distribution of CBD Line of Beverages 05/15/2017 09:08:43 AM
ADVT News: Advantis Corp. Receiving Larger, Ongoing Amstercan Orders 05/01/2017 07:38:59 AM
ADVT News: Advantis Corp. Co-Brands, Launches Natural Elements Tea 04/24/2017 08:53:59 AM
ADVT News: Advantis Corp. Set To File for California Commercial Distribution License 04/18/2017 09:39:35 AM
PostSubject
#41509  Sticky Note $$$ADVT$$ Out with %300 higher Rev. Quarter look buckyeye1978 05/18/17 08:07:14 PM
#40936  Sticky Note Advantis Corp. Set To File for California Commercial Teslonian 04/18/17 09:30:37 AM
#40918  Sticky Note $ADVT Advantis Announces Exciting New Projects Will Be $Pistol Pete$ 04/14/17 03:13:20 AM
#37769  Sticky Note ADVT NEW DD _ post_: Bran 'NEW Products: mightymoe 02/12/17 09:23:16 AM
#36360  Sticky Note Advantis Corp. Packages Hemperor's Club Premium Cannabis Papa Bear 01/30/17 11:19:38 AM
#41676   Sure, we have a great buying opportunity because sir90 05/25/17 11:06:19 PM
#41675   The vul is starting to pick back up buckyeye1978 05/25/17 04:35:17 PM
#41674   Here our the number that just release last buckyeye1978 05/25/17 03:05:47 PM
#41673   Exactly buy when there blood our the street buckyeye1978 05/25/17 02:56:38 PM
#41672   Not even close the company has don't done buckyeye1978 05/25/17 02:50:10 PM
#41671   Am not a Dem. U not going shame buckyeye1978 05/25/17 02:44:43 PM
#41670   It would be nice to see real numbers. Winniep28 05/25/17 02:20:17 PM
#41669   Yeah, I knew this would drop when that surfstocks 05/25/17 12:27:14 PM
#41668   People are disappointed in the Q1 #'s, so GilHal 05/25/17 12:18:30 PM
#41667   So ADVT is a pump & dump play alert1100 05/25/17 11:36:22 AM
#41665   You say lots of positive things, but I DMoneyLove 05/25/17 12:42:34 AM
#41664   O O is there chance we could go buckyeye1978 05/24/17 03:18:46 PM
#41663   I never got that or heard of that buckyeye1978 05/24/17 03:09:40 PM
#41662   again he said LESSER FEE. That's an DaBenDan 05/24/17 02:47:51 PM
#41661   Is that u again with u 4990 free buckyeye1978 05/24/17 02:42:45 PM
#41660   You smoke to much litar 05/24/17 02:33:19 PM
#41659   U be getting for free with secret brokerage buckyeye1978 05/24/17 02:25:16 PM
#41658   I got great Idea why don't u call buckyeye1978 05/24/17 02:19:08 PM
#41657   I buy more in 000's this summer litar 05/24/17 02:15:54 PM
#41656   Buying Freebie's u mean .. buy when there buckyeye1978 05/24/17 02:12:48 PM
#41655   Shemale litar 05/24/17 01:42:10 PM
#41654   This the wash out sell off I been buckyeye1978 05/24/17 01:35:25 PM
#41653   Well, at least she includes the I'm a DaBenDan 05/24/17 01:28:32 PM
#41652   No it's a woman Risk vs Reward 05/24/17 01:26:30 PM
#41651   It is probably a guy. It and DaBenDan 05/24/17 01:25:52 PM
#41650   Next drop could be sorrowful.. probably tomorrow. sir90 05/24/17 01:20:32 PM
#41649   Yeah if she's here there's a major downtrend Risk vs Reward 05/24/17 01:02:39 PM
#41648   Booyah, in come the koolaid pumpers like Cabroncita, .... DaBenDan 05/24/17 12:56:44 PM
#41647   Can't wait the next interviews litar 05/24/17 12:56:20 PM
#41646   Yep this will dry on low 00's for litar 05/24/17 12:54:57 PM
#41645   Spring fluff cycle ending and we need to DaBenDan 05/24/17 12:53:34 PM
#41644   Three months. Probably not building them a DaBenDan 05/24/17 12:50:17 PM
#41643   LOL, no way. I have dead money DaBenDan 05/24/17 12:30:06 PM
#41642   Relaxe nothing you can do....they are crooks thats all. litar 05/24/17 12:03:12 PM
#41641   WOO puts out this fantasy optimistic BS and sir90 05/24/17 12:01:15 PM
#41640   Ha ha i told you please don't cry litar 05/24/17 11:59:07 AM
#41639   I can't believe Swartz approved WOO'S February 27th PR sir90 05/24/17 11:54:55 AM
#41637   Do you believe the fully reporting ? They litar 05/24/17 11:43:16 AM
#41636   Buck are you buying cheapies? litar 05/24/17 11:40:22 AM
#41635   Fiasco of 2017! litar 05/24/17 11:39:43 AM
#41634   This is dead money sir90 05/24/17 11:35:13 AM
#41633   Unfortunately we are on the same page now DaBenDan 05/24/17 10:31:47 AM
#41632   Simple they are crooks and they sold millions litar 05/24/17 10:17:52 AM
#41631   Now problems with rosin press mentioned as well sir90 05/24/17 10:14:52 AM
#41630   Bingo was all bs crap....don't forget the press litar 05/24/17 10:05:15 AM
#41629   Not only were Q1 revenues too low to sir90 05/24/17 10:01:17 AM
#41628   Told you! litar 05/24/17 10:00:17 AM
#41627   Sorry i said down to 0.006 but im litar 05/24/17 09:55:36 AM
#41626   Subpenny litar 05/24/17 09:54:25 AM
#41625   The steep slide for the last few months sir90 05/24/17 09:43:40 AM
PostSubject